Quantbot Technologies LP Lowers Stock Position in Trupanion, Inc. $TRUP

Key Points

• Quantbot Technologies LP has reduced its stake in Trupanion, Inc. by 22.5%, now holding 24,117 shares valued at approximately $899,000.
• Insider sales were notable, with COO John R. Gallagher and CFO Fawwad Qureshi selling 4,000 and 2,534 shares, respectively, leading to significant decreases in their stock ownership.
• Trupanion's latest earnings report revealed a profit of $0.22 per share, exceeding analysts' expectations and showing a 12.3% increase in revenue compared to the prior year.

Quantbot Technologies LP cut its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 22.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,117 shares of the financial services provider's stock after selling 6,986 shares during the quarter. Quantbot Technologies LP owned 0.06% of Trupanion worth $899,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP raised its position in shares of Trupanion by 13.2% in the 1st quarter. Wellington Management Group LLP now owns 2,491,227 shares of the financial services provider's stock valued at $92,848,000 after buying an additional 290,788 shares in the last quarter. Balyasny Asset Management L.P. grew its holdings in Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after acquiring an additional 661,559 shares during the last quarter. Hosking Partners LLP grew its holdings in Trupanion by 86.9% during the 1st quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider's stock worth $14,821,000 after acquiring an additional 184,936 shares during the last quarter. Northern Trust Corp grew its holdings in Trupanion by 9.0% during the 4th quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock worth $17,749,000 after acquiring an additional 30,549 shares during the last quarter. Finally, BNP Paribas Financial Markets grew its holdings in Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after acquiring an additional 212,545 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Stifel Nicolaus boosted their target price on shares of Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a report on Friday, August 8th. Cantor Fitzgerald raised shares of Trupanion to a "hold" rating in a research note on Wednesday, August 13th. Lake Street Capital reduced their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Finally, Piper Sandler upped their price objective on shares of Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a research note on Friday, August 8th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $54.17.

Trupanion Stock Up 0.5%

Shares of Trupanion stock traded up $0.22 during trading on Friday, reaching $46.44. 205,102 shares of the company traded hands, compared to its average volume of 595,907. The firm has a market capitalization of $2.00 billion, a PE ratio of 178.85 and a beta of 1.78. Trupanion, Inc. has a 1-year low of $31.00 and a 1-year high of $57.90. The company has a 50 day moving average price of $50.30 and a 200-day moving average price of $44.07. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.25. The business had revenue of $353.56 million for the quarter, compared to analyst estimates of $346.73 million. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. Trupanion's revenue was up 12.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.14) earnings per share. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Trupanion news, insider Brenna Mcgibney sold 2,390 shares of the firm's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $45.17, for a total value of $107,956.30. Following the transaction, the insider directly owned 1,317 shares of the company's stock, valued at approximately $59,488.89. This trade represents a 64.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 2,800 shares of the firm's stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total transaction of $127,568.00. Following the completion of the transaction, the chief financial officer directly owned 6,451 shares in the company, valued at $293,907.56. This trade represents a 30.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,390 shares of company stock worth $245,238 over the last ninety days. Insiders own 5.42% of the company's stock.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.